NBY
NovaBay Pharmaceuticals Inc
NYSE MKT: NBY · HEALTHCARE · BIOTECHNOLOGY
$1.95
+22.64% today
Updated 2026-04-02
Market cap
$51.92M
P/E ratio
—
P/S ratio
0.16x
EPS (TTM)
$-28.50
Dividend yield
—
52W range
$1 – $100
Volume
1.3M
NovaBay Pharmaceuticals Inc (NBY) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-64.9%
Last 4 quarters
Revenue YoY growth
-78.7%
Most recent quarter
EPS YoY growth
+61.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.9%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+0.9%
2025-11-07
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-07 | $-0.23 | -2200.0% | $1.07 | $1.08 | +0.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $-0.01 | $-0.23 | -2200.0% | $521000.00 | -78.7% |
| 2025-06-30 | $-0.21 | $-0.34 | -61.9% | — | — |
| 2025-03-31 | $-0.24 | $-0.40 | -66.7% | $2.31M | -12.2% |
| 2024-12-31 | $-1.20 | $-1.99 | -66.2% | $2.31M | -38.0% |
| 2024-09-30 | $-0.30 | $-0.59 | -96.7% | $2.44M | -25.0% |
| 2024-06-30 | $-1.23 | $-1.37 | -11.4% | $2.40M | -32.1% |
| 2024-03-31 | $-0.15 | $-0.15 | +0.0% | $2.63M | +12.5% |
| 2023-12-31 | $-0.30 | $-1.33 | -343.3% | $3.73M | — |
| 2023-09-30 | $-0.40 | $-0.37 | +7.5% | $3.25M | — |
| 2023-06-30 | $-0.56 | $-0.64 | -14.3% | $3.53M | — |
| 2023-03-31 | $-0.91 | $-0.85 | +6.6% | $2.34M | — |
| 2022-12-31 | $-0.17 | $-0.78 | -358.8% | — | — |
Frequently asked questions
Has NovaBay Pharmaceuticals Inc beaten earnings estimates?
NovaBay Pharmaceuticals Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -64.9% over the last 3 quarters.
How does NBY stock react to earnings?
NBY stock has moved an average of +0.9% in the trading day following earnings over its last 1 reports, with positive reactions in 100% of those quarters.
What is NovaBay Pharmaceuticals Inc's revenue growth rate?
NovaBay Pharmaceuticals Inc reported year-over-year revenue growth of -78.7% in its most recent quarter, with EPS growing +61.0% year-over-year.